Buffalo Grove, Illinois – Oct. 28, 2014
Leica Biosystems is a global leader in anatomical pathology solutions and automation, striving to advance cancer diagnostics to improve patients’ lives. Leica Biosystems provides pathologists, histologists and researchers with a comprehensive range of products for each step in the pathology process.
With the addition of the Mammotome suite of products, Leica Biosystems now brings you the best in tissue acquisition technology as well as the finest in processing, embedding and staining, and digital imaging equipment for your pathology lab. This is an exciting step that will help propel Mammotome’s future and allow us to better serve all of our Mammotome and Neoprobe customers and their patients.
About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.
For more information, please visit www.leicabiosystems.com.